Hospital Safety: NEJM Study Finds No Progress
Two major analyses of U.S. hospital safety found that: "harm to patients was common and the number of incidents did not decrease over time."
Another Risk of Death Linked to Atypical Antipsychotics
"The risk was greater for individuals prescribed atypical rather than conventional drugs."
Antipsychotic Drugs and Risk of Venous Thromboembolism: Nested Case-Control Study BMJ
FDA Urges Florida Not to Bar Foster Kids From Psych Drug Trials
How many children in foster care serve as human guinea pigs in commercial drug trials?
FDA Expands Market for Another Toxic Antipsychotic
According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic antipsychotic drug, Saphris, for treating acute manic-depressive behavior in adults. Antipsychotics (neuroleptics) are a controversial class of drugs: Risperdal (approved in 1993), Zyprexa (1994), Seroquel (1997), Abilify (2002), and Saphris (2009). These drugs’…
Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young
The prescribed drugs transformed Kyle Warren from a rambunctious healthy child into a drooling, sedated, obese, “shell.”
Swedish Suicide Data 2007: Majority Treated With Psych Drugs
The majority of persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of committing suicide.
Chantix Triggers Unprovoked Violence
Pfizer’s smoking cessation drug, Chantix (varenicline), may be the most dangerous drug ever to carry the government seal of approval–it poses a danger, not just to those who ingest the drug, but to people in the community in which they live.
Another Coffin Nail for Avandia
The FDA announced that the postmarketing trial of Avandia, known as TIDE, has been placed on "partial clinical hold." No new patients may be enrolled in the trial.
Columbia Brain Imaging Violations Condemned by Peers
"any slipshod work involving volunteers in clinical trials sends a shudder through the field," said Dr. Gary Small, a professor of psychiatry and biobehavioral sciences at UCLA
Columbia Brain Imaging Research Suspended
“There could be a patient safety issue, for one, and there could be a scientific validity issue. If you’re exposing people to radiation and getting garbage data, then that becomes an ethical problem.”
Devastating FDA Safety Review of Avandia
Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks
Despite the fact that children may be at highest risk of antidepressant-induced suicide, GlaxoSmithKline is testing Paxil on 7 to 18 year old Japanese children.